Table 1.
List of cases used for real time RT-PCR analysis of PBGD. There was no significant difference in age or postmortem interval (PMI) between control and AD groups. A subset of these cases was used for ALAS and ALAD analysis (*).
| Alzheimer Disease (n=13) | ||||
|---|---|---|---|---|
| Age | PMI (hrs) |
Sex | APOE | Braak Stage |
| 65 | 3 | F | 3/3 | V-VI |
| 69 | 8 | M | 3/3 | V-VI |
| 69 | 6 | F | 4/4 | V-VI |
| 72* | 4 | M | 3/4 | III-IV |
| 72* | 5 | M | 3/3 | V-VI |
| 77 | 4 | F | 3/3 | V-VI |
| 78 | 3 | M | 4/4 | V-VI |
| 79 | 2.5 | F | 3/4 | V-VI |
| 80 | 4 | F | 4/4 | V-VI |
| 80* | 5.5 | M | 3/4 | III-IV |
| 83* | 8 | M | 3/4 | III-IV |
| 83* | 3 | F | 3/4 | V-VI |
| 85 | 6 | F | 3/4 | V-VI |
| Control (n=8) | ||||
|---|---|---|---|---|
| Age | PMI (hrs) |
Sex | APOE | Braak Stage |
| 65* | 14 | M | 3/3 | 0 |
| 65 | 2 | M | 3/3 | 0 |
| 65 | 1 | F | 3/3 | 0 |
| 74* | 8 | M | 2/4 | I-II |
| 75* | 17 | F | 3/3 | 0 |
| 79* | 2 | F | 3/3 | I-II |
| 81* | 27 | M | 2/3 | 0 |
| 83 | 6 | M | 3/3 | Lewy body dementia |